Total Bilirubin

Blood

Comprehensive Metabolic Panel (CMP)

Total bilirubin is a pigment produced when the body breaks down old red blood cells, and it is processed by the liver before being excreted. A preventive practice tracks it as a marker of liver function and of red blood cell turnover.

What It Measures

Breakdown product of hemoglobin; liver function and hemolysis marker

Optimal vs. Lab Range

Longevity Optimal

0.3–0.8 mg/dL

Target range for optimal health and longevity based on research.

Standard Lab

0.1–1.2 mg/dL

Population-based reference range from standard labs.

Why It Matters

Bilirubin reflects the balance between how much is produced from red cell breakdown and how well the liver clears it, so it can point to either a liver or a blood-related process. A high level can indicate liver disease, bile duct obstruction, or hemolysis, and is also seen in Gilbert syndrome, a common and benign genetic variant that raises bilirubin without harm. A low level is generally not clinically significant. Because the same value can reflect very different situations, bilirubin is interpreted alongside the liver enzymes and, when hemolysis is suspected, markers of red cell turnover to clarify the underlying cause.

When Low

Generally not clinically significant when low

When High

Liver disease, bile duct obstruction, hemolysis, Gilbert syndrome (benign genetic variant)

How to Optimize

The right approach to an elevated bilirubin depends entirely on its source, so the first step is distinguishing a benign pattern like Gilbert syndrome from a liver or hemolytic cause. When the liver is involved, supporting liver health through the same metabolic and lifestyle measures used for other hepatic markers is appropriate, and if hemolysis is present, addressing its source is the priority. In benign Gilbert syndrome, no treatment is needed. Bilirubin is best read with ALT, AST, ALP, and, where relevant, hemoglobin and LDH. Targets and treatment are individualized with your physician; this content is educational and not a substitute for medical advice.

Key Interventions & Linked Compounds

Strong evidence

Key Interventions

Liver support

address hemolysis source

Linked Compounds & Supplements

NAC

Milk thistle

Curated from clinical literature. Individual results vary; consult a qualified clinician before changing a protocol.

Ordering Notes

Specimen

Serum or plasma (venous draw)

Patient prep

No fasting required. Maintain usual diet and medications unless advised.

Recommended cadence

Annual

Reporting unit

Confirm with the performing lab — units vary by region.

Pre-analytic notes

Standardize draw time of day, hydration, and recent exercise. Note any acute illness, supplements, or hormonal therapies on the requisition.

Recommended Follow-Up Actions

1
Confirm the result is reliable
Repeat abnormal values before acting — preferably from the same lab, same time of day, and under consistent prep. Rule out acute illness, recent intense exercise, or medication effects that can shift Total Bilirubin.
2
Compare against optimal, not just lab range
Use the optimal window above as the target. Lab "normal" is built from the general population and often misses early dysfunction.
3
Pair with related markers
Order a complementary panel covering metabolic, inflammatory, and hormonal context to interpret this marker properly.
4
Discuss interventions with a clinician
Use the interpretation guidance above to frame the conversation. Bring trends, not just one datapoint, to your visit.
5
Re-test on a defined cadence
If a change is implemented, re-measure in 8–12 weeks for fast-moving markers, or 3–6 months for slower ones, to confirm response before escalating.